Efficacy of AMALS in Treating Language Impairment in Children

Sponsor
Lamar University (Other)
Overall Status
Completed
CT.gov ID
NCT00840060
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD) (NIH)
40
3
2
23
13.3
0.6

Study Details

Study Description

Brief Summary

The goal of this proposal is to examine the efficacy of a manualized treatment intervention, AMALS: Addressing Multiple Aspects of Language Simultaneously, which is designed to remediate semantic, morphological, and syntactic aspects of language in preschool children with language impairment. This study will target preschool children with language impairment living in a region characterized by nonmainstream dialects.

Questions driving this work are:
  1. Will children participating in the AMALS treatment exhibit greater semantic, morphological, and syntactic complexity on multiple outcome measures at the completion of the intervention compared to a Discrete Trial Approach (DTA) group?

  2. Will these gains be maintained at one-month follow up?

  3. What is the impact of dialect on dependent variables, specifically morphosyntactic abilities?

To answer these questions a randomized clinical trial will be conducted comparing AMALS, an integrated approach to treatment, with DTA, an additive approach to therapy. In this study rather than restrict the ethnic and cultural backgrounds of this population, children's use of dialect will be uniquely identified and examined.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: AMALS
  • Behavioral: DTA
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
AMALS: Addressing Multiple Aspects of Language Simultaneously: A Randomized Clinical Trial
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: AMALS

Addressing multiple aspects of language simultaneously

Behavioral: AMALS
Addressing multiple aspects of language simultaneously

Experimental: DTA

Discrete Trial Approach

Behavioral: DTA
Discrete Trial Approach

Outcome Measures

Primary Outcome Measures

  1. Language Sample Analysis [Language samples were obtained pre-treatment, post-treatment, and at one-month follow-up.]

    Samples were transcribed and segmented by utterance. Each was coded categorically. Reported measures include percentage of utterances at the interpretive/inferential label, percentage of utterances with one or more t-unit (i.e., noun phrase + verb phrase), percentage of utterances that required copula (is/are) or auxiliary (is/are) that were produced.

  2. Number of Verb Structures Per Utterance [Pre-treatment, post-treatment, 1-month follow-up]

    Samples were transcribed and segmented by utterance. Utterances were analyzed for novel verb structures. Structures were included if they were produced more than one time.

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Demonstrate sufficient intelligibility as determined by a score of 85% on percent consonant correct (PCC) measures;

  2. Demonstrate sufficient phonological ability to use grammatical morphemes as determined by use of word-final /s, z, t, d/ on sound- in-word subtest from the Goldman-Fristoe Test of Articulation-2 (GFTA; Goldman & Fristoe, 2000)

  3. Nonverbal IQ above 70 as scored on the Columbia Mental Maturity Scale (CMMS; Burgemeister, Blum, & Lorge, 1972);

  4. Below 1SD on the Diagnostic Evaluation of Language Variation: Norm-referenced Test (DELV; Seymour, Roeper & de Villiers, 2005);

  5. Below 1.39SD on the Structured Photographic Expressive Language Test-Preschool (SPELT-P; Werner & Kresheck, 1983);

  6. Documentation from teachers and/or parents of impressions of language status in comparison with peers;

  7. More than one standard deviation below the mean on both levels 3 and 4 of the Preschool Language Assessment Instrument (PLAI; Blank, Rose, & Berlin, 1978).

Exclusion Criteria:
  1. English as the primary language

  2. No oral-motor impairment

  3. No hearing impairment

  4. No co-morbid psychiatric or neurological impairments

Contacts and Locations

Locations

Site City State Country Postal Code
1 West Orange Cove Consolidated Independent School District Orange Texas United States 77631
2 Little-Cypress Mauriceville Consolidated School District Orange Texas United States 77632
3 Port Arthur Independent School District Port Arthur Texas United States 77640

Sponsors and Collaborators

  • Lamar University
  • National Institute on Deafness and Other Communication Disorders (NIDCD)

Investigators

  • Principal Investigator: Monica L Bellon-Harn, Ph.D., Lamar University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Monica L. Harn, Associate Professor, Speech and Hearing Services, Lamar University
ClinicalTrials.gov Identifier:
NCT00840060
Other Study ID Numbers:
  • RDC009027A-01A2
  • 1R15DC009027-01A2
  • NIDCD RDC009027A-01A2
First Posted:
Feb 10, 2009
Last Update Posted:
May 15, 2012
Last Verified:
May 1, 2012
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details Children were recruited at three public school sites. From January 2009 to May 2010, 50 participants were successfully recruited. Of the 50, 40 met inclusion criteria and were randomly assigned to one of the two treatments.
Pre-assignment Detail No participants were excluded from the treatment following enrollment.
Arm/Group Title Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach
Arm/Group Description Children assigned to this treatment group participated in language treatment that followed a scaffolded-language structure. Linguistic content and structures were not explicitly targeted. Children assigned to this treatment group participated in a language treatment following an additive structure. Linguistic content and structure were explicitly targeted.
Period Title: Overall Study
STARTED 20 20
COMPLETED 19 19
NOT COMPLETED 1 1

Baseline Characteristics

Arm/Group Title Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach Total
Arm/Group Description Children assigned to this treatment group participated in language treatment that followed a scaffolded-language structure. Linguistic content and structures were not explicitly targeted. Children assigned to this treatment group participated in a language treatment following an additive structure. Linguistic content and structure were explicitly targeted. Total of all reporting groups
Overall Participants 20 20 40
Age (Count of Participants)
<=18 years
20
100%
20
100%
40
100%
Between 18 and 65 years
0
0%
0
0%
0
0%
>=65 years
0
0%
0
0%
0
0%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
4.56
(.50)
4.90
(.51)
4.74
(.53)
Sex: Female, Male (Count of Participants)
Female
9
45%
6
30%
15
37.5%
Male
11
55%
14
70%
25
62.5%
Region of Enrollment (participants) [Number]
United States
20
100%
20
100%
40
100%

Outcome Measures

1. Primary Outcome
Title Language Sample Analysis
Description Samples were transcribed and segmented by utterance. Each was coded categorically. Reported measures include percentage of utterances at the interpretive/inferential label, percentage of utterances with one or more t-unit (i.e., noun phrase + verb phrase), percentage of utterances that required copula (is/are) or auxiliary (is/are) that were produced.
Time Frame Language samples were obtained pre-treatment, post-treatment, and at one-month follow-up.

Outcome Measure Data

Analysis Population Description
Language samples were collected for all children participating in either treatment condition.
Arm/Group Title Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach
Arm/Group Description Children assigned to this treatment group participated in language treatment that followed a scaffolded-language structure. Linguistic content and structures were not explicitly targeted. Children assigned to this treatment group participated in a language treatment following an additive structure. Linguistic content and structure were explicitly targeted.
Measure Participants 19 19
Interpretive utterances: pre-treatment
17.33
(3.31)
18.00
(3.22)
Interpretive utterances: post-treatment
39.35
(4.04)
26.38
(3.92)
Interpretive utterances: 1-month follow-up
39.70
(4.16)
20.55
(4.04)
T-units: pre-treatment
52.30
(21.00)
53.77
(22.70)
T-units: post-treatment
80.94
(13.18)
69.78
(20.19)
T-units: one-month follow-up
74.88
(16.99)
55.83
(29.48)
Frequency of copula (is/are): pre-treatment
56.00
(33.24)
71.00
(33.59)
Frequency of copula (is/are): post-treatment
77.05
(26.78)
76.43
(26.12)
Frequency of copula (is/are): 1-month follow-up
76.94
(25.72)
75.81
(23.55)
Frequency of auxiliary (is/are): pre-treatment
40.11
(38.87)
48.87
(35.13)
Frequency of auxiliary (is/are): post-treatment
65.23
(23.73)
59.12
(26.02)
Frequency of auxiliary (is/are): 1-month follow-up
50.23
(34.15)
48.68
(24.51)
2. Primary Outcome
Title Number of Verb Structures Per Utterance
Description Samples were transcribed and segmented by utterance. Utterances were analyzed for novel verb structures. Structures were included if they were produced more than one time.
Time Frame Pre-treatment, post-treatment, 1-month follow-up

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach
Arm/Group Description Children assigned to this treatment group participated in language treatment that followed a scaffolded-language structure. Linguistic content and structures were not explicitly targeted. Children assigned to this treatment group participated in a language treatment following an additive structure. Linguistic content and structure were explicitly targeted.
Measure Participants 19 19
Novel verb structures per utterance: pre-treatment
3.52
(2.26)
4.15
(2.16)
Novel verb structure per utterance: post-treatment
5.94
(1.59)
4.61
(1.78)
Novel verb structures per utterance: 1-month follo
5.41
(2.78)
4.16
(2.20)

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach
Arm/Group Description Children assigned to this treatment group participated in language treatment that followed a scaffolded-language structure. Linguistic content and structures were not explicitly targeted. Children assigned to this treatment group participated in a language treatment following an additive structure. Linguistic content and structure were explicitly targeted.
All Cause Mortality
Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%)
Other (Not Including Serious) Adverse Events
Addressing Multiple Aspects of Language Simultaneously Discrete Trial Approach
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%)

Limitations/Caveats

Problems with stratification according to dialect prior to randomization lead to difficulty interpreting results related to dialect

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Monica Harn
Organization Lamar University
Phone 409-880-8174
Email monica.harn@lamar.edu
Responsible Party:
Monica L. Harn, Associate Professor, Speech and Hearing Services, Lamar University
ClinicalTrials.gov Identifier:
NCT00840060
Other Study ID Numbers:
  • RDC009027A-01A2
  • 1R15DC009027-01A2
  • NIDCD RDC009027A-01A2
First Posted:
Feb 10, 2009
Last Update Posted:
May 15, 2012
Last Verified:
May 1, 2012